Analysts Issue Forecasts for Astrana Health Q1 Earnings

Astrana Health, Inc. (NASDAQ:ASTH - Free Report) - Analysts at William Blair issued their Q1 2026 EPS estimates for shares of Astrana Health in a research note issued to investors on Wednesday, July 2nd. William Blair analyst R. Daniels expects that the company will earn $0.34 per share for the quarter. The consensus estimate for Astrana Health's current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health's Q4 2026 earnings at $0.48 EPS.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The firm had revenue of $620.39 million during the quarter, compared to the consensus estimate of $628.11 million. During the same quarter in the previous year, the company posted $0.31 earnings per share. The firm's revenue was up 53.4% on a year-over-year basis.

Other research analysts also recently issued research reports about the company. Truist Financial lowered their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Barclays assumed coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price target for the company. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $53.29.

Astrana Health Trading Up 2.5%

Astrana Health stock traded up $0.63 during trading hours on Thursday, hitting $25.28. The stock had a trading volume of 159,835 shares, compared to its average volume of 297,884. The business's 50 day simple moving average is $26.65 and its 200-day simple moving average is $30.70. Astrana Health has a one year low of $23.12 and a one year high of $63.20. The stock has a market cap of $1.42 billion, a price-to-earnings ratio of 35.10, a P/E/G ratio of 1.36 and a beta of 0.84. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.54.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in ASTH. Truist Financial Corp bought a new stake in shares of Astrana Health during the 4th quarter valued at about $315,000. US Bancorp DE boosted its holdings in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock worth $151,000 after buying an additional 4,656 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Astrana Health by 5.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company's stock worth $14,861,000 after buying an additional 23,533 shares in the last quarter. Victory Capital Management Inc. grew its position in shares of Astrana Health by 38.6% during the 4th quarter. Victory Capital Management Inc. now owns 62,116 shares of the company's stock worth $1,959,000 after buying an additional 17,310 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Astrana Health by 348.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company's stock valued at $1,191,000 after acquiring an additional 29,355 shares in the last quarter. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.